SLC17A7 and Alzheimer disease: These data showed that compared to non-AD control, treatment with AD brain extracts did not lead to loss of neurons yet caused a significantly increased loss of dendrite segments and branches, as well as the number of presynaptic vGlut1 puncta per neuron (Fig. 6), showing neurotoxicity of AD brain extracts.